rewirebio.iobenchmarks
Configuration

Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)

Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026) as run in Kaschta et al. 2026.

1 evaluation · 8 results

Overview

Manual diagnostic reanalysis by laboratory experts: Expert re-interpretation of a case in a diagnostic laboratory using a tertiary interpretation platform and current literature.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

1 evaluation · 8 results. Different protocols are not a single leaderboard.

Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026) · Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)

Sorted by Count (cases with a new P/LP finding) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationCount (cases with a new P/LP finding)Count (cases with newly reported findings (P/LP or VUS))Count (cohort cases with a reported P/LP finding after reanalysis (158 before))Count (cohort cases without a reported clinically relevant finding after reanalysis (170 before))Diagnostic yield (total P/LP diagnostic rate in the 377-case cohort after reanalysis)Review time per case (mean hands-on time for full manual case reanalysis, excluding report writing and secondary-review preparation)Count (cases newly classified as VUS findings)Count (cohort cases with VUS findings after reanalysis (49 before))
Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Evaluationthreefive16116642.7%81 minutestwo50
All 8 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
five Count (cases with newly reported findings (P/LP or VUS))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Reanalysis Diagnostic Yield: Manual Reanalysis P1, 'identified five cases with newly reported findings'
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
three Count (cases with a new P/LP finding)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Abstract P3, 'Manual reanalysis identified three additional P/LP cases'
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
two Count (cases newly classified as VUS findings)
count · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Abstract P3, 'two newly classified as VUS'
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
166 Count (cohort cases without a reported clinically relevant finding after reanalysis (170 before))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Reanalysis Diagnostic Yield: Manual Reanalysis P3, 'decreased from 170 to 166'
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
161 Count (cohort cases with a reported P/LP finding after reanalysis (158 before))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Reanalysis Diagnostic Yield: Manual Reanalysis P3, 'increased the number of cases with a reported P/LP finding from 158 to 161'
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
81 minutes Review time per case (mean hands-on time for full manual case reanalysis, excluding report writing and secondary-review preparation)
minute · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Reanalysis Diagnostic Yield: Manual Reanalysis P3, 'The mean reanalysis time was 81 minutes per case'
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
42.7% Diagnostic yield (total P/LP diagnostic rate in the 377-case cohort after reanalysis)
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Reanalysis Diagnostic Yield: Manual Reanalysis P3, 'yielding a total diagnostic rate of 42.7%'
Configuration: Manual reanalysis in Illumina Emedgene with DRAGEN v4.2.4 re-calling (Kaschta et al. 2026)Protocol: Manual versus Talos reanalysis of 219 unresolved genomes after a mean 660 days (Kaschta et al. 2026)
Dataset: UKSH rare-disease genomes without a prior P/LP finding: 219 cases (Kaschta et al. 2026)
50 Count (cohort cases with VUS findings after reanalysis (49 before))
count · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Manual reanalysis of 219 unresolved genomes

reanalysis-kaschta-20261010-protocol-manual-vs-talos-219-reanalysis

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Reanalysis Diagnostic Yield: Manual Reanalysis P3, 'The number of cases with VUS findings increased from 49 to 50'

Source checking is not independent reproduction. Release 2026-10-10-cbb3da59bc08.

Use this configuration

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-10-cbb3da59bc08
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-10-cbb3da59bc08 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: reanalysis-kaschta-20261010-config-manual-emedgene-dragen-4-2-4

areas
dna-genomes
contexts
clinical_research
method types
conventional_pipeline
reported name
Manual reanalysis (Illumina Emedgene)
foundation model eligible
false
version
DRAGEN germline v4.2.4 (small variants), v4.2 (SMN copy number, STR and SV calling); Emedgene version not printed
parameters
Raw FASTQ re-aligned and re-called; updated annotation, allele frequencies, curated clinical information and current literature; mean time recorded per case
source locator
Methods 'Manual Reanalysis of Previously No-Finding and Cases with VUS Findings' P1-P3; Results 'Cohort' P2
Related records

Suggest a correction